Abstract:SUMOylation, which is a type of post-translational modification that involves covalent conjugation of small ubiquitin-like modifier (SUMO) proteins to target substrates, regulates various important molecular and cellular processes, including transcription, the cell cycle, cell signaling, and DNA synthesis and repair. Newly synthesized SUMO is immature and cleaved by the SUMO-specific protease family, resulting in exposure of the C-terminal Gly–Gly motif to become the mature form. In the presence of ATP, mature SUMO is conjugated with the activating enzyme E1 through the cysteine residue of E1, followed by transfer to the cysteine residue of E2-conjugating enzyme Ubc9 in humans that recognizes and modifies the lysine residue of a substrate protein. E3 SUMO ligases promote SUMOylation. SUMOylation is a reversible modification and mediated by SUMO-specific proteases. Cumulative studies have indicated that SUMOylation affects the functions of protein substrates in various manners, including cellular localization and protein stability. Gene knockout studies in mice have revealed that several SUMO cycling machinery proteins are crucial for the development and differentiation of various cell lineages, including immune cells. Aberrant SUMOylation has been implicated in several types of diseases, including cancers, cardiovascular diseases, and autoimmune diseases. This review summarizes the biochemistry of SUMO modification and the general biological functions of proteins involved in SUMOylation. In particular, this review focuses on the molecular mechanisms by which SUMOylation regulates the development, maturation, and functions of immune cells, including T, B, dendritic, and myeloid cells. This review also discusses the underlying relevance of disruption of SUMO cycling and site-specific interruption of SUMOylation on target proteins in immune cells in diseases, including cancers and infectious diseases.

Exploration on effects of sumoylation on kidney diseases

SUMOylation Plays a Role in Gemcitabine- and Bortezomib-Induced Cytotoxicity in Human Oropharyngeal Carcinoma KB Gemcitabine-Resistant Clone.

Role and mechanism of post-translational SUMOylation in atherosclerosis

The role and mechanism of SUMO modification in liver disease

Effects of angiotensin Ⅱand losartan on expression of SUMO in rat glomerular mesangial cells

Signalling mechanisms and cellular functions of SUMO

The Critical Roles of the SUMO-Specific Protease SENP3 in Human Diseases and Clinical Implications

The emerging roles of SUMOylation in pulmonary diseases

SUMO and the robustness of cancer

SUMOylation at the crossroads of gut health: insights into physiology and pathology

Sumoylation As an Emerging Target in Therapeutics Against Cancer

Mechanisms and functions of SUMOylation in health and disease: a review focusing on immune cells

SUMO proteases: from cellular functions to disease

Sumoylation as an Emerging Target in Therapeutics against Cancer.

SUMO modification regulates the transcriptional activity of XBP1.

Sumoylation in Cellular Senescence and Aging

The post-translational modification, SUMOylation, and cancer (Review)

Research progress of small ubiquitin-related modifierylation in the regeneration of spinal cord injury

Natural Products Against Renal Fibrosis via Modulation of SUMOylation

Do Foreign-Owned Firms Provide Better Working Conditions than Their Domestic Counterparts? A Comparative Analysis

SUMOylation Wrestles With the Occurrence and Development of Breast Cancer